Clinical trial
Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling…
NCT00147563 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00147563 |
|---|---|
| Title | Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT |
| Official title | A Double-Blind, Parallel Design Study to Compare the Effectiveness of Eplerenone Versus Atenolol in Reversing the Remodeling of Resistance Arteries in Subjects With Mild to Moderate Primary Hypertension |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Eplerenone |
| Enrollment | 34 |
| Start date | Oct 1, 2003 |
| Primary completion | May 1, 2006 |
| First posted | Sep 7, 2005 |
| Last update posted | Apr 15, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: